FDA Deals with Avandia
July 15, 2010
Tom Costello (NBC Nightly News) reports that drug maker Glaxo Smith Kline has agreed to pay 460-million dollars to settle most of the lawsuits connected to its one-time blockbuster diabetes drug, Avandia.
Topics:
Health Medical Pharma, Entertainment Culture, Television in the United States, GlaxoSmithKline, pharmaceutical industry, Business, NBC, Blockbuster Inc., Food and Drug Administration, NBC Nightly News, Rosiglitazone, Glaxo Smith Kline, USD, Avandia, FDA, Tom Costello, blockbuster diabetes, drug maker